{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:32:29Z","timestamp":1740126749026,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000277","name":"Department for Environment, Food and Rural Affairs, UK Government","doi-asserted-by":"publisher","award":["SE3226"],"award-info":[{"award-number":["SE3226"]}],"id":[{"id":"10.13039\/501100000277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.tube.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T14:41:19Z","timestamp":1459435279000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis"],"prefix":"10.1016","volume":"98","author":[{"given":"M. Carmen","family":"Garcia-Pelayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryan A.","family":"Kaveh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi C.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon M.","family":"Cutting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.03.004_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.20506\/rst.20.1.1266","article-title":"Epidemiology of selected mycobacteria that infect humans and other animals","volume":"20","author":"Ashford","year":"2001","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.tube.2016.03.004_bib2","series-title":"Tuberculosis: pathogenesis, protection and control","article-title":"The BCG experience: implications for future vaccines against tuberculosis","author":"Bloom","year":"1994"},{"key":"10.1016\/j.tube.2016.03.004_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1211\/jpp.58.6.0005","article-title":"Development of vaccines against bovine tuberculosis","volume":"58","author":"Hogarth","year":"2006","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.tube.2016.03.004_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.03.004_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect\/Inst Pasteur"},{"key":"10.1016\/j.tube.2016.03.004_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.tube.2011.12.003","article-title":"BCG: myths, realities, and the need for alternative vaccine strategies","volume":"92","author":"McShane","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.03.004_bib7","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.vaccine.2012.02.036","article-title":"Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis","volume":"30","author":"Brennan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2016.03.004_bib9","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A\u00a0gamma interferon independent mechanism of CD4 T cell mediated control of M.\u00a0tuberculosis infection in\u00a0vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2016.03.004_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","article-title":"Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization","volume":"86","author":"Xing","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.03.004_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1574-695X.2008.00415.x","article-title":"Immunostimulatory activity of Bacillus spores","volume":"53","author":"Huang","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.tube.2016.03.004_bib12","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1016\/j.vaccine.2008.09.024","article-title":"Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses","volume":"26","author":"Huang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib13","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/j.vaccine.2012.03.016","article-title":"Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine","volume":"30","author":"Song","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vaccine.2006.07.037","article-title":"Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen","volume":"25","author":"Duc le","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib15","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/IAI.00786-13","article-title":"Mucosal vaccination against tuberculosis using inert bioparticles","volume":"81","author":"Reljic","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.004_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3155-1-6","article-title":"Emerging applications of bacterial spores in nanobiotechnology","volume":"1","author":"Ricca","year":"2003","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.tube.2016.03.004_bib17","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","article-title":"Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family","volume":"70","author":"Skjot","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.004_bib18","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/IAI.02086-05","article-title":"High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection","volume":"74","author":"Hervas-Stubbs","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.004_bib19","doi-asserted-by":"crossref","first-page":"e21566","DOI":"10.1371\/journal.pone.0021566","article-title":"Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge","volume":"6","author":"Kaveh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.03.004_bib20","doi-asserted-by":"crossref","first-page":"e38926","DOI":"10.1371\/journal.pone.0038926","article-title":"The duration of antigen-stimulation significantly alters the diversity of multifunctional CD4 T cells measured by intracellular cytokine staining","volume":"7","author":"Kaveh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.03.004_bib21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tube.2016.03.004_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.resmic.2008.11.002","article-title":"Bacillus subtilis isolated from the human gastrointestinal tract","volume":"160","author":"Hong","year":"2009","journal-title":"Res Microbiol"},{"key":"10.1016\/j.tube.2016.03.004_bib24","series-title":"Molecular biological methods for Bacillus","first-page":"391","article-title":"Sporulation, germination and outgrowth","author":"Nicholson","year":"1990"},{"key":"10.1016\/j.tube.2016.03.004_bib25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.vaccine.2009.10.127","article-title":"Mucosal delivery of antigens using adsorption to bacterial spores","volume":"28","author":"Huang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tube.2008.05.005","article-title":"Development of a Mycobacterium bovis intranasal challenge model in mice","volume":"88","author":"Logan","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.03.004_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S0022172400052943","article-title":"A\u00a0selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis","volume":"79","author":"Gallagher","year":"1977","journal-title":"J\u00a0Hyg (Lond)"},{"key":"10.1016\/j.tube.2016.03.004_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/trstmh\/tru206","article-title":"Aerosol immunisation for TB: matching route of vaccination to route of infection","volume":"109","author":"Manjaly Thomas","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tube.2016.03.004_bib29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.03.004_bib30","doi-asserted-by":"crossref","first-page":"e87454","DOI":"10.1371\/journal.pone.0087454","article-title":"Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action","volume":"9","author":"de Souza","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.03.004_bib31","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2015.10.115","article-title":"Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy","volume":"33","author":"Orr","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/mi.2014.136","article-title":"Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge","volume":"8","author":"Monin","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.tube.2016.03.004_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","article-title":"IL-23 and IL-17 in tuberculosis","volume":"41","author":"Khader","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.tube.2016.03.004_bib34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/jiv503","article-title":"Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism","volume":"213","author":"Aguilo","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.03.004_bib35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.vaccine.2003.09.031","article-title":"Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner","volume":"22","author":"Mauriello","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.004_bib36","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.71.5.2810-2818.2003","article-title":"Bacterial spores as vaccine vehicles","volume":"71","author":"Duc le","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.004_bib37","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/IAI.00686-08","article-title":"Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis","volume":"76","author":"Hoang","year":"2008","journal-title":"Infect Immun"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T19:39:17Z","timestamp":1616355557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215302833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":37,"alternative-id":["S1472979215302833"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.03.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"type":"print","value":"1472-9792"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}